Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Group Lifestyle Intervention for People With New Onset Type 2 Diabetes. [NA]
This document reports the completion of a clinical trial evaluating a group lifestyle intervention for individuals with new-onset Type 2 Dia…
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial sponsored by Brigham and Women's Hospital evaluated a long-acting insulin injection to reduce C-reactive protein in patients w…
-
CLINICAL_TRIALS research · 2010-11-22Clinical Trial Update: A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase III randomized trial comparing Acarmet (metformin HCl 500 mg plus acarbose 50 mg) thrice daily versus acarbose 50 mg thrice daily in s…
-
CLINICAL_TRIALS trial_result · 2010-11-22Clinical Trial Update: Exercise and Acarbose in Type 2 Diabetes [Phase 4]
Phase 4 trial examining the combination of exercise and acarbose for type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: GALLANT 6 Tesaglitazar vs. Pioglitazone [Phase 3]
Phase 3 trial comparing Tesaglitazar to Pioglitazone for Type 2 diabetes mellitus has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-11-19FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Metformin Hydrochloride (Sun Pharmaceutical Industries, Inc.), a generic metformin product.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating the safety and tolerability of adding oral tesaglitazar to insulin therapy in patients with Type 2 diabetes was ter…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 study evaluating the safety and tolerability of tesaglitazar in patients with Type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
A completed clinical trial update evaluating Crestor (rosuvastatin) in patients with type 2 diabetes mellitus for lowering LDL cholesterol t…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: GALLANT 5 Tesaglitazar Versus Metformin [Phase 3]
A Phase 3 trial comparing tesaglitazar with metformin for type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-11-18Clinical Trial Update: A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes [NA]
A completed clinical trial comparing insulin glargine and insulin detemir in adults with type 2 diabetes to evaluate their comparative effic…
-
CLINICAL_TRIALS trial_result · 2010-11-17Clinical Trial Update: Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing once-daily insulin detemir vs NPH insulin in older adults with type 2 diabetes; study terminated with results posted…
-
CLINICAL_TRIALS research · 2010-11-16Clinical Trial Update: Skin and Retina Microvascular Endothelial Function in Healthy, Insulin Resistant and Type 2 Diabetic Subjects
A clinical trial assessing skin and retina microvascular endothelial function across healthy, insulin-resistant, and type 2 diabetic subject…
-
FDA approval · 2010-11-12FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP, indicating regulatory action…
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin [Phase 1]
A Phase 1 pharmacokinetic study evaluated the interaction between AZD1656 and simvastatin in individuals with Type 2 Diabetes Mellitus; the …
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients [Phase 1]
Phase 1 trial assessing how AZD1656 affects the pharmacokinetics and pharmacodynamics of warfarin in patients with Type 2 Diabetes Mellitus;…
-
CLINICAL_TRIALS trial_result · 2010-11-05Clinical Trial Update: Vildagliptin and Endothelium-dependent Vasodilatation [Phase 3]
A Phase 3 trial update on vildagliptin assessing endothelium-dependent vasodilatation in type 2 diabetes with endothelial dysfunction; the s…
-
CLINICAL_TRIALS trial_result · 2010-11-05Clinical Trial Update: Therapeutic Exploratory Study of CWP-0403 [Phase 2]
A Phase 2 exploratory trial of CWP-0403 for type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating insulin glargine for improving glycemic control in adults wi…
-
FDA approval · 2010-11-01FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories, LLC's metformin hydrochloride as an original ANDA, providing a generic version of metformin for type 2…
-
CLINICAL_TRIALS trial_result · 2010-11-01Clinical Trial Update: The Effect of an Alginate Based Beverage on Weight Loss [NA]
The University of Copenhagen-sponsored trial evaluating an alginate-based beverage for weight loss has completed. The study targeted individ…
-
CLINICAL_TRIALS research · 2010-10-28Clinical Trial Update: Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria [Phase 3]
A Phase 3 clinical trial comparing the antiproteinuric effects of imidapril versus ramipril in adults with type 2 diabetes and hypertension …
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance [Phase 2]
This clinical trial update describes a Phase 2 study evaluating fish gelatin and omega-3 supplements in obese or overweight adults with insu…
-
CLINICAL_TRIALS research · 2010-10-25Clinical Trial Update: Korea National Diabetes Program
A clinical trial update for the Korea National Diabetes Program sponsored by Kyunghee University Medical Center, focusing on Type 2 Diabetes…
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles [NA]
This completed clinical trial compared glycemic control in people with type 1 or type 2 diabetes using three different insulin pen needle de…